Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-21

Clinical Trial Update: Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia [Phase 3]

View source ↗

Summary

Phase 3 trial update on Melodic-Intonation-Therapy and Speech-Repetition-Therapy for non-fluent aphasia shows completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Aphasia, Stroke | Phase 3 | Status: COMPLETED